MindMaze Therapeutics Announces CHF 4 Million Financing
GENEVA, Nov. 17, 2026 /PRNewswire/ -- MindMaze Therapeutics (SIX: MMTX) (the Company), a global leader in scalable precision neurotherapeutics, today announced that it has signed agreements securing investment commitments of up to CHF 4 million from long-term strategic investors. The...